Clinical Trials Logo

Clinical Trial Summary

The investigators' goal is to perform an observational cohort study investigating the use of oxygen reserve index (ORi) in patients undergoing elective thoracic surgery and one-lung ventilation (OLV). For this purpose, ORi values are recorded and compared to the other collected hemodynamical and oximeter parameters. The primary hemodynamic parameters include heart rate (HR) and blood pressure (BP), while; oximeter device-related parameters include peripheral oxygen saturation, perfusion index (PI), and pleth variability index (PVI). The investigators' secondary goal is to investigate relationships between these hemodynamical and oximeter parameters using statistical analysis methods.


Clinical Trial Description

The main objective of this study is to investigate the possible benefits of using the oxygen reserve index (ORi) parameter during one-lung ventilation (OLV) and elective thoracic operations. For this purpose, ORi values are compared to primary hemodynamical parameters of blood pressure (BP) and heart rate (HR) and Meanwhile, a device from Masimo Inc, USA, provides oximeter-related parameters, including peripheral oxygen saturation, perfusion index (PI), and pleth variability index (PVI). The secondary objective is to investigate possible statistically significant correlations between these hemodynamical and oximeter parameters using appropriate statistical methods. The study participants are patients undergoing video-assisted thoracotomy surgical procedures (VATS) or open thoracotomy for suspicion and possible lung tumor removal. The surgical operation of either lobectomy, pneumonectomy, lung biopsy, or wedge resection is considered during this procedure. The inclusion and exclusion criteria are summarized in another section of the clinicaltrials.gov registration document. All patients in the study receive a similar anesthetic management protocol. Premedication is not required in the study. After admitting a patient to the operating theatre, pulse oximetry SpO2, electrocardiogram, and noninvasive blood pressure monitoring are established. Heart rate (HR), mean arterial pressure (MAP), systolic blood pressure (SBP), and diastolic blood pressure (DBP) are measured at certain time points. Anesthesia requires induction of anesthesia with intravenous doses of propofol (Pofol, Fresenius Pharmaceutical, Turkey), 2 to 3 mg/kg, rocuronium (Esmeron, Organon Pharmaceuticals, U.S.A.) at a dose of 0.6 mg/kg, and fentanyl (Janssen fentanyl, Janssen Pharmaceutical, Belgium) at a dose of 2 to 3 mcg/kg. Tracheal intubation requires the use of a left Robertshaw double-lumen tube. During anesthesia, one-lung ventilation (OLV) is provided to all patients in addition to mechanical ventilation. The anesthesia maintenance includes inhalational anesthetic of sevoflurane (Sevorane, Abbott Pharmaceutical, USA) at an end-tidal concentration of 1 to 2% to provide a sufficient minimum alveolar concentration to establish anesthesia and intravenous fentanyl boluses at a dose of 0.2 mcg/kg every hourly to provide analgesia and to keep mean arterial blood pressure between 60 and 80 mmHg. In addition to standard follow-up parameters, oxygen reserve index (ORi), perfusion index (PI), pleth variability index (PVI) is monitored for each patient at certain time points. Hypoxemia during OLV was defined as peripheral oxygen saturation (SpO2) value of less than 95% when the inspired oxygen fraction (FiO2)value is equal to or greater than 60% on a pulse oximetry device. Hemodynamic and oximeter data were continuously monitored. The parameters that are in need of investigation include; MAP, SBP, DBP, HR, SpO2, PaO2, ORi, PI, and PVI values. These data are monitored at thirteen different time points during the period of anesthesia induction and maintenance of the surgery. The device used in this study is called the Radical-7 Pulse CO-Oximeter device for the measurement of ORi, PI, and PVI. A correlation between these values was investigated on the continuous graphs. The duration of surgery, anesthesia, OLV, and total 100% oxygen application time are recorded. Blood gas analysis was provided at DL5 at a 5-minute time point and blood gas analysis was performed for prolonged surgeries and for surgeries with high bleeding performance that required other analysis. Routinely, patients are ventilated with 50% FiO2 (50% oxygen + 50% air mixture, 1 liter/minute fresh gas flow) after induction. The value of FiO2 rises depending on pulse oximeter values between the values of 60% and 100% in order to keep SpO2 values greater than 94. The incidence of thromboembolic complications, arrhythmia, pneumonia, the duration of hospital and intensive care unit stay is recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05050552
Study type Observational [Patient Registry]
Source Trakya University
Contact
Status Completed
Phase
Start date March 1, 2020
Completion date August 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT03508050 - Clamping the Double Lumen Tube N/A
Completed NCT02919267 - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms N/A
Not yet recruiting NCT03649386 - Heated Circuit for One-lung Ventilation N/A
Recruiting NCT02959515 - The Effects of Different Types of Non-ventilated Lung Management on DO2 During OLV in the Supine Position N/A
Completed NCT02981537 - Two-staged Approach in Positioning Endobronchial Blockers Without Fiberoptic Guidance N/A
Completed NCT03503565 - Intraoperative Neuromuscular Blockade and Postoperative Atelectasis
Completed NCT03296449 - Comparison Between CPAP and HFJV During One-lung Ventilation in VATS N/A
Recruiting NCT04725318 - Esophageal Pressure Measurements During One-lung Ventilation
Completed NCT02137291 - IPg2 Study: Left-sided Lung Isolation N/A
Completed NCT00486616 - Examination of Double-Lumen Tube Placement by Functional Electrical Impedance Tomography N/A
Not yet recruiting NCT06376123 - Nomogram for Prediction of Alveolo-arterial Gradient During One-lung Ventilation
Completed NCT04260451 - Driving Pressure and Postoperative Pulmonary Complications in Thoracic Surgery N/A
Completed NCT04760262 - The Effect of Anesthesia on Cerebral Oxygenation
Recruiting NCT05907525 - Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation N/A
Unknown status NCT01171560 - Evaluation of the EZ Blocker Phase 4
Completed NCT05946707 - Effects of Oxygen Supply After Lung Isolation in Thoracic Surgery N/A
Completed NCT03234621 - Protective Ventilation Strategy N/A
Completed NCT04740151 - Individualized PEEP in Thoracic Surgery N/A
Not yet recruiting NCT06210256 - Compared Unidirectional Valve Apparatus and Occluding the Non-ventilated Endobronchial Lumen for Lung Collapse. N/A
Active, not recruiting NCT02963025 - Protective Ventilation With High Versus Low PEEP During One-lung Ventilation for Thoracic Surgery N/A